Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 119
Vaccine Safety Research, Data Access, and Public Trust Appendix D Meeting One—Agenda The National Academies Institute of Medicine Committee on Review of NIP’s Research Procedures and Data Sharing Program Meeting One AGENDA Speakers and Times Subject to Change Monday, August 23, 2004 10:30 a.m. – 5:45 p.m. Meeting Location: Keck Center of the National Academies Room 100 500 Fifth Street, NW Washington, DC 20001 10:00–10:30 a.m. Registration and Coffee
OCR for page 120
Vaccine Safety Research, Data Access, and Public Trust 10:30–10:45 a.m. Welcome, Introductions, and Opening Statement John Bailar, MD, PhD Committee Chair 10:45–10:55 a.m. Description of the Vaccine Safety Datalink (VSD) Robert Davis, MD, MPH Visiting Scientist Office of Genomics and Disease Prevention Centers for Disease Control and Prevention 10:55–11:15 a.m. Background on the NCHS Research Data Center (RDC) Jennifer Madans, PhD Associate Director for Science National Center for Health Statistics Centers for Disease Control and Prevention 11:15–11:40 a.m. Description of the VSD Data Sharing Program Melinda Wharton, MD, MPH Acting Deputy Director National Immunization Program Centers for Disease Control and Prevention 11:40–11:45 a.m. Future Plans for the VSD Data Sharing Program Jennifer Madans, PhD 11:45 a.m. – 12:05 p.m. Questions from the Committee 12:05–12:15 p.m. Charge to the Committee Roger Bernier, PhD, MPH Senior Advisor For Scientific Strategy and Innovation National Immunization Program Centers for Disease Control and Prevention 12:15–12:30 p.m. Questions from the Committee 12:30–1:15 p.m. Lunch (Cafeteria on 3rd Floor)
OCR for page 121
Vaccine Safety Research, Data Access, and Public Trust 1:15–1:45 p.m. Researchers’ Experience with the VSD Data Sharing Program Mark R. Geier, MD, PhD President The Genetic Centers of America David Geier President MedCon 1:45–2:15 p.m. Questions from the Committee 2:15–2:25 p.m. RDC Monitor’s Experience with the VSD Data Sharing Program Peter Shabe, MS Director of Data Management and Statistics TrialTech 2:25–2:40 p.m. NIP’s Experience with the VSD Data Sharing Program Roger Bernier, PhD, MPH 2:40–3:00 p.m. Questions from the Committee 3:00–3:10 p.m. Break 3:10–3:30 p.m. Perspective and Experience of a Managed Care Organization Involved in the VSD Data Sharing Program Richard Platt, MD, MSc Professor and Chair Department of Ambulatory Care and Prevention Harvard Medical School Harvard Pilgrim Health Care 3:30–3:45 p.m. Questions from the Committee 3:45–4:05 p.m. Access to California Health Interview Survey Data through the UCLA Data Access Center Lee Habte, MA Data Access Center Manager UCLA Center for Health Policy Research
OCR for page 122
Vaccine Safety Research, Data Access, and Public Trust 4:05–4:20 p.m. Questions from the Committee 4:20–4:40 p.m. Perspective of a Consumer Group on Access to VSD Data Barbara Loe Fisher President National Vaccine Information Center 4:40–4:55 p.m. Questions from the Committee 4:55–5:40 p.m. Public Comment (A sign-up sheet will be available at the registration table) 5:40–5:45 p.m. Closing Remarks John Bailar, MD, PhD Committee Chair
Representative terms from entire chapter: